Details of the Drug

General Information of Drug (ID: DMHEV75)

Drug Name

Preclamol

Synonyms

UNII-9V2O6CRQ6Z; CHEMBL7549; 9V2O6CRQ6Z; Preclamol [INN]; Preclamolum [Latin]; 85966-89-8; Preclamolum; 3-(1-Propyl-piperidin-3-yl)-phenol; (-)-(S)-m-(1-Propyl-3-piperidyl)phenol; AC1NSK6E; Lopac0_000996; SCHEMBL1240854; DTXSID7048453; ZINC402947; 3PPP,(+); 3-PPP-(-); PDSP2_000626; BDBM50010617; PDSP1_000630; CCG-205076; NCGC00162308-01; NCGC00162310-02; (S)-3-(1-propylpiperidin-3-yl)phenol; 3-[(3S)-1-propylpiperidin-3-yl]phenol; 3-((S)-1-Propyl-piperidin-3-yl)-phenol; (-)-3-(1-Propyl-piperidin-3-yl)-phenol; FT-0770905

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

219.32

Logarithm of the Partition Coefficient (xlogp)

3

Rotatable Bond Count (rotbonds)

3

Hydrogen Bond Donor Count (hbonddonor)

1

Hydrogen Bond Acceptor Count (hbondacc)

2

Chemical Identifiers

Formula: C14H21NO
IUPAC Name: 3-[(3S)-1-propylpiperidin-3-yl]phenol
Canonical SMILES: CCCN1CCC[C@H](C1)C2=CC(=CC=C2)O
InChI: InChI=1S/C14H21NO/c1-2-8-15-9-4-6-13(11-15)12-5-3-7-14(16)10-12/h3,5,7,10,13,16H,2,4,6,8-9,11H2,1H3/t13-/m1/s1
InChIKey: HTSNFXAICLXZMA-CYBMUJFWSA-N

Cross-matching ID

PubChem CID: 5311189
CAS Number: 85966-89-8
TTD ID: D06FUV

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Dopamine D2 receptor (D2R)	TTEX248	DRD2_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Dopamine D2 receptor (D2R)	DTT	DRD2	2.50E-02	-0.08	-0.49

Molecular Expression Atlas (MEA)

MEA Detail

Jump to Detail Molecular Expression Atlas of This Drug

References

1	Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). ... J Med Chem. 1990 Mar;33(3):1015-22.